Helius Medical Technologies is trading at $1.90 (13.3% up) today, reversing recent downward pressure and Friday’s decline despite a lack of fresh company-specific catalysts.
- The move appears driven by low-liquidity pre-market buying rather than fundamental news, earnings, or analyst updates.
- Broader market sentiment remains mixed, with index futures providing little direction for the stock's early gains.